The National Cancer Institute’s Investigational New Drug program facilitates collaboration, not collusion, with industry for ...

Genesis has gained US Food and Drug Administration (FDA) clearance on an Investigational New Drug (IND) application for a ...

An investigational PCSK9 inhibitor with a different mechanism from existing drugs in this class has been shown to safely and ...

In a landmark decision poised to revolutionize drug development, the U.S. Food and Drug Administration (FDA) has announced a ...

AI-driven drug discovery firms rallied on Friday after the U.S. Food and Drug Administration (FDA) announced an initiative to ...

today announced that the U.S. Food and Drug Administration (FDA) has cleared Altesa's new Investigational New Drug (IND) application for vapendavir for the treatment of rhinovirus infections in ...

The FDA will begin replacing animal testing in the development of monoclonal antibody therapies and other drugs with ...

Apr. 9, 2025 — FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune ...

The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...

Cardiol Therapeutics (TSX: CRDL) has reached a major milestone with the announcement that the first patients have been ...

AXS-12, known as reboxetine back when it was available as an antidepressant in the United States, may decrease cataplexy ...